A class action against implant maker Exactech has been stayed in light of its US bankruptcy, but a carve out allows the firm that brought the case to continue settlement negotiations.
A judge has signed off on a $38 million settlement in a shareholder class action against Mayne Pharma but has slashed a 27.9 per cent commission for the funder that backed the case. Victorian Supreme Court Justice Andrew Watson approved the settlement on 19 December, including $6 million in legal costs and a 25.7 per…
ANZ Bank New Zealand has lost its bid to appeal a ruling that common fund orders can be made in class actions, including at an early stage of the proceeding,
Maurice Blackburn is stuck paying $5.4 million in security in a flex commissions class action against Macquarie, with a judge saying it represents a “business risk willingly undertaken”.
US drug maker Pfizer is facing a class action investigation into the possible link between its injectable contraceptive Depo-Provera and brain tumors.
Class action settlements leaped in value last year, with three settlements topping the $200 million mark.
Hino Motors has agreed to pay $87 million to settle a consumer class action alleging it misrepresented that its vehicles met Australian emissions and road standards over a 20-year period.
Women who were allegedly injured by defective pelvic mesh implants can apply to set aside two approved settlements against Johnson & Johnson and Boston Scientific worth $405 million.
A judge has approved a $56 million settlement in a class action alleging Monash IVF destroyed potentially viable embryos, including a $10.6 million payout for the firm that ran the case.
Johnson & Johnson has been hit with a class action for allegedly pushing ineffective cold and flu medications containing phenylephrine onto customers for decades.